2022 ICD-10-CM Code R87.616
Satisfactory cervical smear but lacking transformation zone

Version 2022
No Valid Principal Dx
ICD-10:R87.616
Short Description:Satisfactory cervical smear but lacking transformation zone
Long Description:Satisfactory cervical smear but lacking transformation zone
Status: Valid for Submission

Code Classification

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
      • Abnormal findings in specimens from female genital organs (R87)

R87.616 is a billable diagnosis code used to specify a medical diagnosis of satisfactory cervical smear but lacking transformation zone. The code R87.616 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.

The ICD-10-CM code R87.616 might also be used to specify conditions or terms like satisfactory for evaluation but limited by absence of an endocervical/transformation zone component from a patient with a cervix.

The code R87.616 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The code is commonly used in ob/gyn medical specialties to specify clinical concepts such as abnormal female genital cytology.

According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.

Entries in the Index to Diseases and Injuries with references to R87.616

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R87.616 are found in the index:

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Convert R87.616 to ICD-9 Code

Information for Patients


Cervical Cancer Screening

The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat.

Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix. With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer. If your screening tests are abnormal, your doctor may do more tests, such as a biopsy.

Cervical cancer screening has risks. The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)